ask="6.50"
ask_size="200"
average_daily_volume="129817"
bid="N/A"
bid_size="N/A"
book_value="3.27"
change="+0.05"
change_from_200_day_moving_average="-3.57"
change_from_50_day_moving_average="0.40"
change_from_52_week_high="-11.65"
change_From_52_week_low="1.55"
change_in_percent="+0.83%"
close="6.05"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.53"
ebitda="-19.33M"
eps_estimate_current_year="-2.82"
eps_estimate_next_quarter="-0.90"
eps_estimate_next_year="-2.84"
ex_dividend_date="N/A"
float_shares="6447000"
high="6.10"
high_52_weeks="17.70"
last_trade_date="3/2/2017"
last_trade_price="6.05"
last_trade_size="260"
last_trade_time="4:00pm"
low="5.90"
low_52_weeks="4.50"
market_capitalization="47.29M"
moving_average_200_day="9.62"
moving_average_50_day="5.65"
name="Trillium Therapeutics Inc."
notes="N/A"
one_year_target_price="16.91"
open="6.05"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-37.11%"
percent_change_from_50_day_moving_average="+7.08%"
percent_change_from_52_week_high="-65.82%"
percent_change_from_52_week_low="+34.44%"
previous_close="6.00"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.84"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="7817000"
short_ratio="2.30"
stock_exchange="NCM"
symbol="TRIL"
volume="27462"
weeks_range_52="4.50 - 17.70"
